ATRA Atara Biotherapeutics, Inc. - Common Stock
$8,87
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 12, 2026
52 Haftlık Aralık
$4–$19
33% of range
Analist Derecelendirmesi
BUY
10 analysts
Fiyat Hedefi
$14
+54% upside
P/E (TTM)
3.5
ROE
-88.9%
Net Kâr Marjı
27.1%
Atara Biotherapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
ATRA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$8.87
Piyasa Değeri
$65M
P/E (TTM)
3.5
EPS (TTM)
$2.57
Gelir (TTM)
$121M
Temettü Verimi
—
ROE
-88.9%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$4 – $19
ATRA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$121M
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$2.57
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-51M
2016-12-31
→
2025-12-31
Marjlar
27.1%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ATRA
Akran Ortalaması
P/E (TTM)
3.5
2.6
P/S (TTM) (F/S (TTM))
0.5
1.9
P/B (F/D)
-1.7
3.1
Price / FCF (Fiyat / Serbest Nakit Akışı)
-1.3
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ATRA
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
29.7%
—
Net Profit Margin (Net Kâr Marjı)
27.1%
-351.5%
ROA
50.5%
-60.9%
ROE
-88.9%
-99.5%
ROIC
-93.0%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ATRA
Akran Ortalaması
Current Ratio (Cari Oran)
0.8
2.6
Quick Ratio (Cari Oran)
0.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ATRA
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-6.3%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
23.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ATRA
Akran Ortalaması
ATRA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
10 analist
- Güçlü Al 2 20,0%
- Al 6 60,0%
- Tut 2 20,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
3 analist · 2026-08-14
Medyan
$13.00
Ortalama
$13.67
← Tüm hedeflerin altında
$8.87
Düşük
$10.00
Yüksek
$18.00
Medyan hedef
$13.00
+46,6%
Ortalama hedef
$13.67
+54,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
1.5%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.29 | $-0.41 | 0.12% |
| 31 Aralık 2025 | $-0.25 | $-0.17 | -0.08% |
| 30 Eylül 2025 | $-0.32 | $-0.88 | 0.56% |
| 30 Haziran 2025 | $0.19 | $-0.47 | 0.66% |
| 31 Mart 2025 | $3.50 | $-2.02 | 5.5% |
| 31 Aralık 2024 | $-1.19 | $-3.65 | 2.5% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| FBIO | — | — | — | — | — | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| ACET | — | -0.5 | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $121M | $129M | $9M | $64M | |
| R&D Expense | $37M | $151M | $225M | $273M | |
| SG&A Expense | $26M | $40M | $51M | $72M | |
| Operating Expenses | $85M | $212M | $285M | $344M | |
| Operating Income | $36M | $-83M | $-276M | $-281M | |
| Interest Expense | $4M | $5M | $5M | $373.0K | |
| Interest Income | $683.0K | $2M | $5M | $3M | |
| Other Non-op | $-34.0K | $528.0K | $-246.0K | $-700.0K | |
| Pretax Income | $33M | $-85M | $-276M | $-228M | |
| Income Tax | $31.0K | $-12.0K | $15.0K | $12.0K | |
| Net Income | $33M | $-85M | $-276M | $-228M | |
| EPS (Basic) | $2.61 | $-11.41 | $-65.19 | $-2.24 | |
| EPS (Diluted) | $2.57 | $-11.41 | $-65.19 | $-2.24 | |
| Shares (Basic) | 12,544,000 | 7,488,000 | 4,236,000 | 101,990,000 | |
| Shares (Diluted) | 12,718,000 | 7,488,000 | 4,236,000 | 101,990,000 | |
| EBITDA | $36M | $-83M | $-276M | $-281M |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $25M | $26M | $93M | |
| Short-term Investments | $0 | $17M | $26M | $150M | |
| Receivables | $1M | $1M | $34M | $40M | |
| Inventory | $0 | $11M | $10M | $2M | |
| Other Current Assets | $2M | $10M | $6M | $10M | |
| Current Assets | $12M | $65M | $102M | $295M | |
| PP&E (Net) | $73.0K | $1M | $4M | $6M | |
| PP&E (Gross) | $286.0K | $19M | $20M | $19M | |
| Accum. Depreciation | $213.0K | $17M | $16M | $12M | |
| Other Non-current Assets | $886.0K | $3M | $5M | $7M | |
| Total Assets | $20M | $109M | $166M | $376M | |
| Accounts Payable | $127.0K | $4M | $4M | $7M | |
| Accrued Liabilities | $2M | $6M | $19M | $7M | |
| Current Liabilities | $15M | $135M | $142M | $79M | |
| Capital Leases | $9M | $30M | $46M | $58M | |
| Other Non-current Liabilities | $2M | $3M | $5M | $6M | |
| Total Liabilities | $59M | $206M | $265M | $250M | |
| Common Stock | $1.0K | $1.0K | $0 | $10.0K | |
| Retained Earnings | $-2.02B | $-2.05B | $-1.97B | $-1.69B | |
| AOCI | $1.0K | $8.0K | $-204.0K | $-2M | |
| Stockholders' Equity | $-39M | $-97M | $99M | $127M | |
| Liabilities + Equity | $20M | $109M | $166M | $376M | |
| Shares Outstanding | 7,324,000 | 5,859,000 | 4,258,000 | 95,927,000 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $2M | $5M | $5M | $6M | |
| Stock-based Comp | $10M | $27M | $45M | $54M | |
| Deferred Tax | $0 | $0 | · | · | |
| Restructuring | $13M | $5M | $7M | $6M | |
| Operating Cash Flow | $-51M | $-69M | $-193M | $-270M | |
| CapEx | $0 | $246.0K | $1M | $4M | |
| Investing Cash Flow | $18M | $9M | $124M | $203M | |
| Stock Issued | $1M | $9M | $2M | $22M | |
| Net Stock Activity | $1M | $9M | $2M | $22M | |
| Financing Cash Flow | $16M | $59M | $2M | $53M | |
| Taxes Paid | $190.0K | $24.0K | $2.0K | $19.0K | |
| Free Cash Flow | $-51M | $-69M | $-194M | $-275M | |
| Levered FCF | $-55M | $-74M | $-199M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | 29.7% | -64.7% | -3219.5% | · | |
| Net Margin | 27.1% | -66.2% | -3220.9% | · | |
| Pretax Margin | 27.1% | -66.2% | -3220.7% | · | |
| EBITDA Margin | 29.7% | -64.7% | -3219.5% | · | |
| ROA | 50.5% | -62.2% | -101.9% | -54.1% | |
| ROE | -88.9% | 90.9% | 368.0% | -145.5% | |
| ROIC | -93.0% | 85.8% | 278.2% | -221.5% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.5 | 0.7 | 3.7 | |
| Quick Ratio | 0.7 | 0.3 | 0.6 | 3.6 | |
| Interest Coverage | 9.5 | -18.1 | -52.2 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.9 | 0.9 | 0.0 | · | |
| Receivables Turnover | 88.3 | 7.2 | 0.2 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -6.3% | 1404.0% | -86.5% | · | |
| Revenue CAGR 3Y | 23.8% | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $121M | $129M | $9M | $64M | |
| Net Income TTM | $33M | $-85M | $-276M | $-228M | |
| Market Cap | $132M | $78M | $1.37B | $7.87B | |
| P/E | 7.0 | -1.2 | -0.2 | -36.6 | |
| P/S | 1.1 | 0.6 | 159.2 | 123.7 | |
| P/B | -3.4 | -0.8 | -13.8 | 62.1 | |
| P / Tangible Book | · | · | 13.8 | 62.1 | |
| P / Cash Flow | -2.6 | -1.1 | -7.1 | -29.1 | |
| P / FCF | -2.6 | -1.1 | -7.0 | -28.6 | |
| Earnings Yield | 14.2% | -85.7% | -508.3% | -2.7% |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $630.0K | $516.0K | $2M | $3M | $18M | $98M | $33M | $40M | $29M | $27M | $4M | $2M | $957.0K | $1M | $221.0K | $4M | |
| R&D Expense | $1M | $164.0K | $-223.0K | $3M | $7M | $27M | $29M | $44M | $33M | $46M | $50M | $57M | $56M | $62M | $63M | $70M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $7M | $11M | $9M | $10M | $9M | $11M | $11M | $12M | $13M | $14M | $13M | $19M | |
| Operating Expenses | $5M | $4M | $4M | $7M | $14M | $59M | $45M | $62M | $47M | $59M | $64M | $72M | $72M | $76M | $76M | $89M | |
| Operating Income | $-5M | $-3M | $-3M | $-4M | $3M | $39M | $-12M | $-22M | $-18M | $-31M | $-60M | $-70M | $-71M | $-75M | $-76M | $-85M | |
| Interest Expense | $191.0K | $830.0K | $894.0K | $909.0K | $972.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $117.0K | $123.0K | |
| Interest Income | $78.0K | $54.0K | $100.0K | $204.0K | $143.0K | $236.0K | $597.0K | $459.0K | $450.0K | $604.0K | $711.0K | $1M | $2M | $2M | $1M | $973.0K | |
| Other Non-op | $0 | $0 | $-49.0K | $4.0K | $22.0K | $-11.0K | $-89.0K | $555.0K | $-6.0K | $68.0K | $-12.0K | $-27.0K | $-10.0K | $-197.0K | $-68.0K | $-309.0K | |
| Pretax Income | $-5M | $-4M | $-3M | $-4M | $2M | $38M | $-13M | $-22M | $-19M | $-32M | $-60M | $-70M | $-71M | $-75M | $-75M | $-84M | |
| Income Tax | $1.0K | $0 | $0 | $28.0K | $3.0K | $0 | $-19.0K | $-17.0K | $0 | $24.0K | $11.0K | $-19.0K | $1.0K | $22.0K | $2.0K | $10.0K | |
| Net Income | $-5M | $-4M | $-3M | $-4M | $2M | $38M | $-13M | $-22M | $-19M | $-32M | $-60M | $-70M | $-71M | $-75M | $-75M | $-84M | |
| EPS (Basic) | $-0.32 | $-0.29 | $-0.80 | $-0.32 | $0.20 | $3.53 | $0.27 | $-2.93 | $-3.10 | $-5.65 | $-31.16 | $-16.40 | $-16.91 | $-0.72 | $-0.73 | $-0.82 | |
| EPS (Diluted) | $-0.32 | $-0.29 | $-0.80 | $-0.32 | $0.19 | $3.50 | $0.27 | $-2.93 | $-3.10 | $-5.65 | $-31.16 | $-16.40 | $-16.91 | $-0.72 | $-0.73 | $-0.82 | |
| Shares (Basic) | 15,033,000 | 14,081,000 | -23,981,000 | 13,564,000 | 12,197,000 | 10,764,000 | -11,744,000 | 7,466,000 | 6,143,000 | 5,623,000 | -108,193,000 | 4,256,000 | 4,204,000 | 103,969,000 | -202,760,000 | 102,423,000 | |
| Shares (Diluted) | 15,033,000 | 14,081,000 | -24,007,000 | 13,564,000 | 12,310,000 | 10,851,000 | -11,744,000 | 7,466,000 | 6,143,000 | 5,623,000 | -108,193,000 | 4,256,000 | 4,204,000 | 103,969,000 | -203,025,000 | 102,423,000 | |
| EBITDA | $-5M | $-3M | · | $-4M | $3M | $39M | · | $-22M | $-18M | $-31M | · | $-70M | $-71M | $-75M | · | $-85M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $8M | $8M | $6M | $17M | $14M | $25M | $46M | $31M | $35M | $26M | $65M | $46M | $49M | $93M | $65M | |
| Short-term Investments | $7M | · | $0 | $8M | $5M | $0 | $17M | $21M | $4M | $11M | $26M | $38M | $108M | $157M | $150M | $200M | |
| Receivables | $318.0K | $0 | $1M | $2M | $0 | $9M | $1M | $1M | $2M | $36M | $34M | $163.0K | $507.0K | $397.0K | $40M | $249.0K | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $11M | $14M | $19M | $16M | $10M | $7M | $8M | $5M | $2M | · | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $16M | |
| Other Current Assets | $3M | $4M | $2M | $3M | $2M | $4M | $10M | $9M | $6M | $8M | $6M | $9M | $10M | $13M | $10M | · | |
| Current Assets | $14M | $12M | $12M | $18M | $25M | $27M | $65M | $92M | $62M | $106M | $102M | $119M | $172M | $224M | $295M | $283M | |
| PP&E (Net) | $41.0K | $55.0K | $73.0K | $147.0K | $176.0K | $285.0K | $1M | $2M | $2M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | |
| PP&E (Gross) | · | · | $286.0K | $551.0K | $551.0K | $2M | $19M | $20M | $20M | $20M | $20M | $20M | $20M | $19M | $19M | $20M | |
| Accum. Depreciation | · | · | $213.0K | $404.0K | $375.0K | $2M | $17M | $18M | $17M | $17M | $16M | $15M | $14M | $13M | $12M | $12M | |
| Other Non-current Assets | $765.0K | $890.0K | $886.0K | $881.0K | $927.0K | $3M | $3M | $3M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $7M | |
| Total Assets | $21M | $20M | $20M | $30M | $37M | $62M | $109M | $143M | $117M | $165M | $166M | $189M | $246M | $302M | $376M | $368M | |
| Accounts Payable | $824.0K | $637.0K | $127.0K | $318.0K | $2M | $1M | $4M | $2M | $5M | $3M | $4M | $7M | $4M | $5M | $7M | $11M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $5M | $9M | $6M | $8M | $11M | $18M | $19M | $8M | $11M | $7M | $7M | · | |
| Current Liabilities | $7M | $6M | $15M | $18M | $15M | $48M | $135M | $156M | $148M | $181M | $142M | $79M | $75M | $68M | $79M | $72M | |
| Capital Leases | $9M | $9M | $9M | $15M | $15M | $27M | $30M | $35M | $39M | $42M | $46M | $49M | $52M | $55M | $58M | $61M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | |
| Total Liabilities | $58M | $57M | $59M | $67M | $72M | $117M | $206M | $233M | $228M | $264M | $265M | $240M | $239M | $237M | $250M | $181M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $12.0K | $0 | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | |
| Retained Earnings | $-2.03B | $-2.03B | $-2.02B | $-2.02B | $-2.01B | $-2.02B | $-2.05B | $-2.04B | $-2.02B | $-2.00B | $-1.97B | $-1.91B | $-1.84B | $-1.77B | $-1.69B | $-1.62B | |
| AOCI | $-2.0K | $0 | $1.0K | $2.0K | $0 | $0 | $8.0K | $22.0K | $-14.0K | $-55.0K | $-204.0K | $-571.0K | $-933.0K | $-1M | $-2M | $-3M | |
| Stockholders' Equity | $-37M | $-37M | $-39M | $-37M | $-35M | $-55M | $-97M | $-91M | $-111M | $-98M | $-99M | $-51M | $7M | $65M | $127M | $187M | |
| Liabilities + Equity | $21M | $20M | $20M | $30M | $37M | $62M | $109M | $143M | $117M | $165M | $166M | $189M | $246M | $302M | $376M | $368M | |
| Shares Outstanding | 9,443,000 | 8,512,000 | 7,324,000 | 7,210,000 | 6,978,000 | 5,924,000 | 5,859,000 | 5,740,000 | 4,904,000 | 120,325,000 | 4,258,000 | 101,922,000 | 101,102,000 | 96,538,000 | 95,927,000 | 94,879,000 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14.0K | $29.0K | $49.0K | $36.0K | $236.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $394.0K | $749.0K | $2M | $1M | $3M | $4M | $6M | $6M | $6M | $8M | $10M | $11M | $13M | $12M | $11M | $14M | |
| Restructuring | $767.0K | $0 | $1M | $27.0K | $2M | $10M | $0 | $0 | $356.0K | $5M | $7M | $0 | $0 | $45.0K | $74.0K | $6M | |
| Operating Cash Flow | $-3M | $-3M | $-6M | $-10M | $-7M | $-28M | $-24M | $-4M | $-11M | $-30M | $-50M | $-51M | $-53M | $-38M | $-57M | $-65M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $90.0K | $0 | $29.0K | $127.0K | $44.0K | $281.0K | $499.0K | $399.0K | $37.0K | $132.0K | |
| Investing Cash Flow | $-7M | $0 | $8M | $-2M | $-5M | $17M | $3M | $-17M | $7M | $15M | $10M | $70M | $49M | $-6M | $51M | $60M | |
| Stock Issued | $5M | $3M | $-25.0K | $1M | $0 | $0 | $0 | $0 | $-26.0K | $9M | $2M | $0 | $-50.0K | $640.0K | $1M | $0 | |
| Net Stock Activity | · | $3M | · | · | · | $0 | · | · | · | $9M | · | · | · | $640.0K | · | · | |
| Financing Cash Flow | $5M | $3M | $-3.0K | $1M | $15M | $-250.0K | $-328.0K | $36M | $-324.0K | $24M | $2M | $-208.0K | $471.0K | $235.0K | $32M | $-214.0K | |
| Taxes Paid | · | · | $159.0K | $28.0K | $3.0K | $0 | $0 | $0 | $0 | $24.0K | $0 | $0 | $1.0K | $1.0K | $0 | $0 | |
| Free Cash Flow | · | · | · | · | · | $-28M | · | · | · | $-30M | · | · | · | $-39M | · | · | |
| Levered FCF | · | · | · | · | · | $-29M | · | · | · | $-31M | · | · | · | $-40M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -749.2% | -652.9% | · | -103.5% | 18.2% | 39.5% | · | -54.1% | -63.7% | -114.2% | · | -3255.9% | -7462.3% | -6118.9% | · | · | |
| Net Margin | -767.3% | -803.3% | · | -124.6% | 13.6% | 38.7% | · | -54.5% | -66.5% | -116.1% | · | -3264.6% | -7430.3% | -6098.8% | · | · | |
| Pretax Margin | -767.1% | -803.3% | · | -123.8% | 13.6% | 38.7% | · | -54.6% | -66.5% | -116.0% | · | -3265.5% | -7430.2% | -6097.0% | · | · | |
| EBITDA Margin | -749.2% | -652.9% | · | -103.5% | 18.2% | 39.5% | · | -54.1% | -63.7% | -114.2% | · | -3255.9% | -7462.3% | -6118.9% | · | · | |
| ROA | -16.7% | -10.1% | · | -5.0% | 3.1% | 33.4% | · | -13.2% | -10.5% | -13.6% | · | -25.1% | -20.8% | -21.4% | · | -20.5% | |
| ROE | 13.4% | 9.0% | · | 6.8% | -3.3% | -49.6% | · | 31.0% | 36.8% | 190.4% | · | -102.4% | -53.7% | -51.7% | · | -33.8% | |
| ROIC | 12.8% | 9.0% | · | 9.8% | -9.1% | -70.5% | · | 24.0% | 16.4% | 31.8% | · | 136.9% | -958.1% | -115.5% | · | -45.2% |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.2 | · | 1.0 | 1.7 | 0.6 | · | 0.6 | 0.4 | 0.6 | · | 1.5 | 2.3 | 3.3 | · | 3.9 | |
| Quick Ratio | 1.5 | 1.5 | · | 0.9 | 1.5 | 0.5 | · | 0.4 | 0.3 | 0.5 | · | 1.3 | 2.1 | 3.0 | · | 3.7 | |
| Interest Coverage | -24.7 | -4.1 | · | -3.9 | 3.3 | 38.2 | · | -18.4 | -14.4 | -27.1 | · | -49.9 | -51.8 | -56.2 | · | · |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.9 | · | 0.2 | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 4.0 | 0.1 | · | 2.1 | 14.5 | 4.4 | · | 53.7 | 19.6 | 1.5 | · | 10.4 | 1.7 | 2.3 | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $120M | · | $159M | $185M | $194M | · | $98M | $59M | $32M | · | $9M | $58M | $65M | · | · | |
| Net Income TTM | $-11M | $32M | · | $14M | $-561.0K | $-35M | · | $-143M | $-192M | $-247M | · | $-300M | $-212M | $-229M | · | $-238M | |
| Market Cap | $108M | $40M | · | $103M | $54M | $35M | · | $47M | $42M | $2.09B | · | $3.77B | $4.07B | $7.00B | · | $8.97B | |
| P/E | -15.5 | 1.5 | · | 32.6 | -3.3 | -0.7 | · | -0.3 | -0.2 | -0.4 | · | -1.1 | -2.2 | -32.5 | · | -39.2 | |
| P/S | 4.9 | 0.3 | · | 0.6 | 0.3 | 0.2 | · | 0.5 | 0.7 | 65.9 | · | 429.5 | 69.9 | 108.4 | · | · | |
| P/B | -2.9 | -1.1 | · | -2.8 | -1.5 | -0.6 | · | -0.5 | -0.4 | -21.2 | · | -74.2 | 545.9 | 107.7 | · | 47.9 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 545.9 | 107.7 | · | 47.9 | |
| P / Cash Flow | · | -13.1 | · | · | · | -1.3 | · | · | · | -70.5 | · | · | · | -182.1 | · | · | |
| P / FCF | · | · | · | · | · | -1.3 | · | · | · | -70.2 | · | · | · | -180.3 | · | · | |
| Earnings Yield | -6.5% | 65.1% | · | 3.1% | -30.3% | -137.7% | · | -345.4% | -494.8% | -228.7% | · | -94.2% | -45.4% | -3.1% | · | -2.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $121M | $129M | $9M | $64M | — |
| Faaliyet Kâr Marjı % | 29.7% | -64.7% | -3219.5% | — | — |
| Net Gelir | $33M | $-85M | $-276M | $-228M | $-340M |
| Seyreltilmiş Hisse Başı Kâr | $2.57 | $-11.41 | $-65.19 | $-2.24 | $-3.63 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 0.8 | 0.5 | 0.7 | 3.7 | 3.6 |
| Cari Oran | 0.7 | 0.3 | 0.6 | 3.6 | 3.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-51M | $-69M | $-194M | $-275M | $-231M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 38 dosya · $53.0M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 7 (0 önceki Ç'ye göre) | 1 (-13 önceki Ç'ye göre) | 10 (+1 önceki Ç'ye göre) | 7 (+3 önceki Ç'ye göre) | +1.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $17.816.960 | 1.552.000 | 33,59% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $9.758.000 | 850.000 | 18,40% | Hisse senetleri |
| Point72 Asset Management, L.P. | $7.895.003 | 687.718 | 14,88% | Hisse senetleri |
| Redmile Group, LLC | $5.070.727 | 441.701 | 9,56% | Hisse senetleri |
| VANGUARD GROUP INC | $3.452.712 | 190.863 | 6,51% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.836.100 | 247.047 | 5,35% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $2.677.699 | 233.249 | 5,05% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $720.986 | 62.764 | 1,36% | Hisse senetleri |
| STALEY CAPITAL ADVISERS INC | $574.000 | 50.000 | 1,08% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $494.053 | 43.036 | 0,93% | Hisse senetleri |
| JANE STREET GROUP, LLC | $348.257 | 30.336 | 0,66% | Hisse senetleri |
| STATE STREET CORP | $303.680 | 26.453 | 0,57% | Hisse senetleri |
| NORTHERN TRUST CORP | $190.201 | 16.568 | 0,36% | Hisse senetleri |
| FMR LLC | $186.412 | 16.238 | 0,35% | Hisse senetleri |
| XTX Topco Ltd | $175.678 | 15.303 | 0,33% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $160.720 | 14.000 | 0,30% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $145.566 | 12.680 | 0,27% | Hisse senetleri |
| BlackRock, Inc. | $117.785 | 10.260 | 0,22% | Hisse senetleri |
| UBS Group AG | $40.341 | 3.514 | 0,08% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $16.715 | 1.456 | 0,03% | Hisse senetleri |
| SBI Securities Co., Ltd. | $16.118 | 1.404 | 0,03% | Hisse senetleri |
| ROYAL BANK OF CANADA | $13.000 | 1.093 | 0,02% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $8.440 | 803 | 0,02% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $3.570 | 311 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $3.490 | 304 | 0,01% | Hisse senetleri |
| Banque Transatlantique SA | $3.096 | 176 | 0,01% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $2.881 | 251 | 0,01% | Hisse senetleri |
| Raiffeisen Bank International AG | $2.296 | 200 | 0,00% | Alım opsiyonu |
| MORGAN STANLEY | $1.906 | 166 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.117 | 100 | 0,00% | Hisse senetleri |
| CITIGROUP INC | $1.114 | 97 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $528 | 46 | 0,00% | Hisse senetleri |
| ACADIAN ASSET MANAGEMENT LLC | $444 | 38.845 | 0,00% | Hisse senetleri |
| CITADEL ADVISORS LLC | $413 | 36 | 0,00% | Hisse senetleri |
| PlanVest Financial, Inc | $321 | 28 | 0,00% | Hisse senetleri |
| KERR FINANCIAL PLANNING Corp | $276 | 24 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $114 | 10 | 0,00% | Hisse senetleri |
| Rockefeller Capital Management L.P. | $92 | 8 | 0,00% | Hisse senetleri |
Şirket yöneticileri 35 içeriden öğrenenler · 19 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Anhco Nguyen | President and CEO | 18 Mayıs 2026 S | 137.837 | 0 | 10 | $-135.918 |
| Isaac E. Ciechanover | Chief Executive Officer | 30 Mayıs 2019 S | 290.687 | 0 | 0 | $0 |
| Utpal Koppikar | Chief Financial Officer | 16 Kasım 2022 S | 191.334 | 0 | 0 | $0 |
| John Mcgrath | EVP & Chief Financial Officer | 20 Mart 2018 S | 88.762 | 0 | 0 | $0 |
| Yanina Grant-Huerta | Chief Accounting Officer | 18 Mayıs 2026 S | 49.636 | 0 | 11 | $-77.525 |
| Jill Henrich | EVP, Chief Regulatory Officer | 03 Mart 2025 S | 18.679 | 0 | 0 | $0 |
| Amar Murugan | EVP, Chief Legal Officer | 16 Ağustos 2024 S | 26.827 | 0 | 0 | $0 |
| Manher Joshi | EVP, Chief Medical Officer | 16 Kasım 2023 S | 171.284 | 0 | 0 | $0 |
| Charlene A. Banard | EVP, Chief Technical Officer | 16 Mayıs 2023 S | 276.010 | 0 | 0 | $0 |
| Jakob Dupont | EVP, Head of R&D | 01 Mart 2023 A | 295.868 | 0 | 0 | $0 |
| Kristin Yarema | Chief Commercial Officer | 01 Mart 2022 A | 171.415 | 0 | 0 | $0 |
| Joe Newell | Chief Operations Officer | 18 Mayıs 2021 S | 128.971 | 0 | 0 | $0 |
| Dietmar Berger | Global Head of R&D | 07 Mayıs 2019 F | 85.678 | 0 | 0 | $0 |
| Mina Kim | Senior VP & General Counsel | 09 Nisan 2019 F | 66.389 | 0 | 0 | $0 |
| Derrell Porter | SVP, Head of Global Commercial | 26 Mart 2019 A | 31.688 | 0 | 0 | $0 |
| Christopher Haqq | EVP, R&D & Chief Scientific Of | 15 Şubat 2019 S | 271.943 | 0 | 0 | $0 |
| Gad Soffer | EVP & Chief Strategy Officer | 22 Eylül 2018 F | 243.966 | 0 | 0 | $0 |
| Mitchall G. Clark | EVP & Chief R & QA Officer | 18 Mayıs 2018 S | 107.972 | 0 | 0 | $0 |
| Heather D Turner | Former EVP, GC & Sec. | 09 Şubat 2018 S | 69.494 | 0 | 0 | $0 |
| Brian N Cherry | Yönetim kurulu üyesi | 11 Haziran 2026 A | 62.320 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Yönetim kurulu üyesi | 09 Haziran 2026 A | 12.000 | 0 | 0 | $0 |
| Matthew K Fust | Yönetim kurulu üyesi | 09 Haziran 2026 A | 30.188 | 0 | 0 | $0 |
| William K Heiden | Yönetim kurulu üyesi | 09 Haziran 2026 A | 34.188 | 0 | 0 | $0 |
| Ameet Mallik | Yönetim kurulu üyesi | 10 Haziran 2025 A | 16.928 | 0 | 0 | $0 |
| Maria Grazia Roncarolo | Yönetim kurulu üyesi | 10 Haziran 2025 A | 17.368 | 0 | 0 | $0 |
| Pascal Touchon | Yönetim kurulu üyesi | 10 Haziran 2025 A | 77.955 | 0 | 0 | $0 |
| Carol Giltner Gallagher | Yönetim kurulu üyesi | 10 Haziran 2025 A | 33.012 | 0 | 0 | $0 |
| Eric Dobmeier | Yönetim kurulu üyesi | 10 Kasım 2023 P | 563.325 | 0 | 0 | $0 |
| Beth C Seidenberg | Yönetim kurulu üyesi | 31 Mayıs 2023 A | 115.689 | 0 | 0 | $0 |
| Roy D. Baynes | Yönetim kurulu üyesi | 23 Haziran 2022 A | 43.500 | 0 | 0 | $0 |
| Ronald C Renaud JR | Yönetim kurulu üyesi | 23 Haziran 2022 A | 31.500 | 0 | 0 | $0 |
| Joel S Marcus | Yönetim kurulu üyesi | 15 Mart 2019 S | 888.355 | 0 | 0 | $0 |
| Eckard Weber | Yönetim kurulu üyesi | 16 Ocak 2015 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10% sahip | 07 Mayıs 2026 P | 1.552.000 | 1 | 0 | $4.744.255 |
| Eric J Hyllengren | — | 31 Mart 2025 D | 56.231 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Redmile Group, LLC, Green Jeremy, Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. ×4 başvurular | 24 Temmuz 2026 | 9,90% | Değişiklik | — | SEC |
| Panacea Innovation Limited, Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Opportunity Fund I, L.P., Panacea Opportunity Fund I GP Company, Ltd., James Huang ×4 başvurular | 11 Mayıs 2026 | 16,10% | Değişiklik | — | SEC |
| Adiumentum Capital Fund I LP, Adiumentum Capital Fund I GP LLC, Gregory A. Ciongoli ×3 başvurular | 16 Mayıs 2025 | 19,99% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 6 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| DCOR · Dimensional ETF Trust | 0,00% | 2.149 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 880 NS | 30 Nisan 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 135 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| IWC · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |